As we continue to monitor the federal takeover of Silicon Valley Bank, we are working to provide as much information as possible on the situation surrounding Silicon Valley Bank. If you're looking for additional information, please check out the resources below:
FDIC FAQ on Silicon Valley…
CMS announced the first 27 drugs to be penalized under the Inflation Reduction Act, and we fact check President Biden’s remarks about drug price controls. Plus, the long-awaited Plant Biostimulant Act was reintroduced yesterday, and we celebrate the first anniversary of ARPA-H. (621 words, 3…
Mr. Delacourt is a senior litigator and regulatory counselor with more than a decade of experience advising biotech companies
WASHINGTON – (March 15, 2023) – The Biotechnology Innovation Organization (BIO) welcomes John Delacourt as Deputy General Counsel – VP Health, Regulatory, and Commercial…
Today, more news and resources on Silicon Valley Bank, plus how you can weigh in on the proposal to expand the waiver of COVID IP. (533 words, 2 minutes, 39 seconds)
Today’s new episode of the I am BIO Podcast explores the power of AI in biotech developments. Plus, we missed National Biobased Products Day—but we explain why we should celebrate them every day. (634 words, 3 minutes, 10 seconds)
"The ecosystem that allows America to develop groundbreaking new medicines is extremely important to our nation and to patients who depend on biotechnology companies. The recent actions by the FDIC, the Federal Reserve, and Treasury to allow SVB depositors to have access to all of their money is a…
We start the week with what you need to know about Silicon Valley Bank and BIO’s response. Plus, The Washington Post looks at how precision fermentation is shaking up the dairy industry. (572 words, 2 minutes, 51 seconds)
A jam-packed Friday as we look at what’s in President Biden’s budget and what 65 ag and biotech groups are saying about the biotech corn dispute with Mexico. Plus, tomorrow is the third anniversary of the COVID pandemic—and we have an exclusive look at what, if anything, we learned. (779 words, 3…
Press Release | March 9, 2023 | BIO Statements, Basic Research, Drug Discovery, Medicare Part D, Pharmacy Benefits Managers (PBM)
President Biden today unveiled details of the White House’s budget request that included drastic changes to the Medicare program, including further expanding the program’s new authority to institute price controls in Medicare. BIO Chief Advocacy Officer, Nick Shipley, made the following statement:
…